Airway reversibility in asthma and phenotypes of Th2-biomarkers, lung function and disease control

10Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: High bronchodilator reversibility in adult asthma is associated with distinct clinical characteristics. In this study, we aim to make a comparison with T-helper 2 (Th2)-related biomarkers, lung function and asthma control between asthmatic patients with high airway reversibility (HR) and low airway reversibility (LR). Methods: Patients with asthma diagnosed by pulmonologist according to Global Initiative for Asthma guidelines were recruited from the outpatient department of our hospital from August 2014 to July 2017. Patients were divided into HR and LR subgroups based on their response to bronchodilators of lung function (HR = Δforced expiratory volume in one second (FEV1) postbronchodilator ≥ 20%). Blood eosinophil count and serum IgE level, which are biomarkers of T-helper (Th)-2 phenotypes, were detected for patients. Asthma Control Test (ACT) was used to assess asthma control after the first-month initial treatment. Results: A total of 265 patients with asthma were followed 1 month after initial treatment. HR group shows a higher level of Th2-high biomarkers (blood eosinophil count (10^9/L): 0.49 ± 0.28 vs 0.36 ± 0.19, P < 0.01; IgE (ng/ml): 1306 ± 842 vs 413 ± 261, P < 0.01), lower baseline lung function (FEV1%pred: 51.91 ± 19.34% vs 60.42 ± 19.22%, P < 0.01; forced expiratory flow (FEF)25-75: 0.76 ± 0.37 vs 1.00 ± 0.67, P < 0.01; FEF25-75%pred: 21.15 ± 10.09% vs 29.06 ± 16.50%, P < 0.01), and better asthma control (ACT score: 22 ± 4 vs 20 ± 4, P = 0.01) than LR group. HR was associated with a decreased risk of uncontrolled asthma after the first-month initial treatment (adjusted OR: 0.12 [95% confidence intervals: 0.03-0.50]). Conclusions: HR is a physiologic indicator of lower lung function and severer small airway obstruction, and is more related with an increased level of Th2-biomarkers than LR. Moreover, HR may indicate controlled asthma after the first-month initial treatment. This finding may contribute to identification of asthma endotype.

References Powered by Scopus

Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma

557Citations
N/AReaders
Get full text

Blood eosinophil count and prospective annual asthma disease burden: A UK cohort study

460Citations
N/AReaders
Get full text

The asthma control test and asthma control questionnaire for assessing asthma control: Systematic review and meta-analysis

241Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways

22Citations
N/AReaders
Get full text

Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA

18Citations
N/AReaders
Get full text

Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II

16Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wei, J., Ma, L., Wang, J., Xu, Q., Chen, M., Jiang, M., … Mo, B. (2018). Airway reversibility in asthma and phenotypes of Th2-biomarkers, lung function and disease control. Allergy, Asthma and Clinical Immunology, 14(1). https://doi.org/10.1186/s13223-018-0315-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

50%

Researcher 2

25%

Professor / Associate Prof. 1

13%

Lecturer / Post doc 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

70%

Biochemistry, Genetics and Molecular Bi... 1

10%

Social Sciences 1

10%

Engineering 1

10%

Save time finding and organizing research with Mendeley

Sign up for free